D-1025-2019 Class II Terminated
FDA drug recall D-1025-2019 was initiated by Advanced Pharma Inc. on Mar 13, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jan 14, 2020). Affected quantity: 140 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 27, 2019
- Initiation Date
- Mar 13, 2019
- Termination Date
- Jan 14, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 140 syringes
Product description
Glycopyrrolate 0.6 mg/3 mL (0.2 mg per mL) Injectable Solution, 3 mL Sterile single use syringe, For IV or IM use, NDC: 42852-828-22 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide
Code information
Lots: 10/31/18 2288 82822S Exp. 3/30/2019; 10/18/18 8371 82822S Exp. 3/17/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1025-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026